SCHEMBL898599

SCHEMBL898599

Cc1cc(NC(C)CNC(=O)O)cc(C)n1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
KDM4E B2RXH2 2/20 0.37
LMNA P02545 1/20 0.37
PRKCI P41743 1/20 0.35
OGG1 O15527 1/20 0.35
RAB9A P51151 3/20 0.34
ALDH1A1 P00352 2/20 0.34
ATM Q13315 1/20 0.34
MAPK1 P28482 1/20 0.34
MAPT P10636 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
THRB P10828 1/20 0.33
NPC1 O15118 1/20 0.33
SORT1 Q99523 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15136109 0.81 PCSK9 (0.41) KMT2AMEN1KDM4ELMNAALDH1A1
SCHEMBL15135628 0.79 SORT1 (0.33) SMN1; SMN2KMT2AMEN1KDM4ELMNA
SCHEMBL15135627 0.79 SORT1 (0.33) SMN1; SMN2KMT2AMEN1KDM4ELMNA
SCHEMBL899398 0.74 SMN1; SMN2 (0.56) CYP2C19SMN1; SMN2KMT2AMEN1KDM4E
SCHEMBL899063 0.73 SYK (0.39) SMN1; SMN2KMT2AMEN1LMNAPRKCI
Hydrochloric Acid SCHEMBL899335 0.72 SYK (0.38) SMN1; SMN2KMT2AMEN1LMNAPRKCI
SCHEMBL12810690 0.69 TDP1 (0.42) CYP2C19LMNAPRKCIALDH1A1ATM
SCHEMBL1425069 0.68 ALOX15 (0.38) SMN1; SMN2KDM4ELMNAOGG1RAB9A
SCHEMBL21816666 0.68 PRKCI (0.51) SMN1; SMN2KMT2AMEN1KDM4EPRKCI
SCHEMBL13603829 0.66 KDM4E (0.49) SMN1; SMN2KMT2AMEN1KDM4EPRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621903-B1 N-HETEROARYL COMPOUNDS INTERVET INT BV (NL) 2017-03-01 EP disclosed
US-8877934-B2 N-heteroaryl compounds INTERVET INC. (US) 2014-11-04 US disclosed
EP-2621903-A1 N-HETEROARYL COMPOUNDS Intervet International B.V. (NL) 2013-08-07 EP disclosed
US-20130196993-A1 N-HETEROARYL COMPOUNDS INTERVET INC. 2013-08-01 US disclosed
WO-2012041873-A1 N-HETEROARYL COMPOUNDS INTERVET INTERNATIONAL B.V. (NL) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130196993-A1 N-HETEROARYL COMPOUNDS HNMT, SQLE, PIGO CYP2D6 78/4885CYP2C19 150/4885SMN1; SMN2 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.